184 related articles for article (PubMed ID: 1385143)
1. Prediction of pelvic lymph node metastases by a prostate-specific antigen and prostatic acid phosphatase in clinical T3/T4M0 prostatic cancer.
Waehre H; Wanderaas EH; Paus E; Fosså SD
Eur Urol; 1992; 22(1):33-8. PubMed ID: 1385143
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen and prostatic acid phosphatase in the detection of early prostate cancer and in the prediction of regional lymph node metastases.
Wirth MP; Frohmüller HG
Eur Urol; 1992; 21(4):263-8. PubMed ID: 1281102
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen and prostate acid phosphatase in the detection of early prostate cancer and the prediction of regional lymph node metastases.
Wirth MP; Frohmüller HG
Eur Urol; 1992; 22(1):27-32. PubMed ID: 1385142
[TBL] [Abstract][Full Text] [Related]
4. DNA ploidy, serum prostate specific antigen, histological grade and immunohistochemistry as predictive parameters of lymph node metastases in T1-T3/M0 prostatic adenocarcinoma.
Berner A; Waere H; Nesland JM; Paus E; Danielsen HE; Fosså SD
Br J Urol; 1995 Jan; 75(1):26-32. PubMed ID: 7531589
[TBL] [Abstract][Full Text] [Related]
5. Utility of preoperative serum prostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer.
Narayan P; Fournier G; Gajendran V; Leidich R; Lo R; Wolf JS; Jacob G; Nicolaisen G; Palmer K; Freiha F
Urology; 1994 Oct; 44(4):519-24. PubMed ID: 7524237
[TBL] [Abstract][Full Text] [Related]
6. Results of laparoscopic pelvic lymphadenectomy in patients at high risk for nodal metastases from prostate cancer.
Kava BR; Dalbagni G; Conlon KC; Russo P
Ann Surg Oncol; 1998 Mar; 5(2):173-80. PubMed ID: 9527271
[TBL] [Abstract][Full Text] [Related]
7. Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection.
Burkhard FC; Bader P; Schneider E; Markwalder R; Studer UE
Eur Urol; 2002 Aug; 42(2):84-90; discussion 90-2. PubMed ID: 12160577
[TBL] [Abstract][Full Text] [Related]
8. The incidence of lymph node metastases in prostate carcinoma depends not only on tumor characteristics but also on surgical performance and extent of pelvic lymphadenectomy.
Klevecka V; Musch M; Roggenbuck U; Stoerkel S; Kroepfl D
Medicina (Kaunas); 2008; 44(8):601-8. PubMed ID: 18791337
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of prostate-specific antigen in untreated prostatic carcinoma.
Oosterom R; Bogdanowicz J; Schröder FH
Eur Urol; 1989; 16(4):253-7. PubMed ID: 2475344
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in "high-risk" prostate cancer compared to MRI or CT.
Borley N; Fabrin K; Sriprasad S; Mondaini N; Thompson P; Muir G; Poulsen J
Scand J Urol Nephrol; 2003; 37(5):382-6. PubMed ID: 14594685
[TBL] [Abstract][Full Text] [Related]
11. The staging pelvic lymphadenectomy: implications as an adjunctive procedure for clinically localized prostate cancer.
Alagiri M; Colton MD; Seidmon EJ; Greenberg RE; Hanno PM
Br J Urol; 1997 Aug; 80(2):243-6. PubMed ID: 9284196
[TBL] [Abstract][Full Text] [Related]
12. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
Arenas LF; Füllhase C; Boemans P; Fichtner J
Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
[TBL] [Abstract][Full Text] [Related]
13. Re-evaluation of the need for pelvic lymphadenectomy in low grade prostate cancer.
Fournier GR; Narayan P
Br J Urol; 1993 Oct; 72(4):484-8. PubMed ID: 7505192
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
Bogdanowicz JF; Bentvelsen FM; Oosterom R; Schroeder FH
Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815
[TBL] [Abstract][Full Text] [Related]
15. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer.
Bluestein DL; Bostwick DG; Bergstralh EJ; Oesterling JE
J Urol; 1994 May; 151(5):1315-20. PubMed ID: 7512662
[TBL] [Abstract][Full Text] [Related]
16. The value of acid phosphatase measurements in predicting extraprostatic cancer growth before radical prostatectomy.
Salo JO; Rannikko S
Br J Urol; 1988 Nov; 62(5):439-42. PubMed ID: 3208023
[TBL] [Abstract][Full Text] [Related]
17. Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer.
Karam JA; Svatek RS; Karakiewicz PI; Gallina A; Roehrborn CG; Slawin KM; Shariat SF
Clin Cancer Res; 2008 Mar; 14(5):1418-22. PubMed ID: 18316564
[TBL] [Abstract][Full Text] [Related]
18. Prediction of lymphatic spreading in prostatic cancer by prostate-specific antigen and Gleason's score.
Wu TT; Chen KK; Huang JK; Lee YH; Chen MT; Chang LS
Eur Urol; 1994; 26(3):202-6. PubMed ID: 7528661
[TBL] [Abstract][Full Text] [Related]
19. Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancer.
Spencer JA; Chng WJ; Hudson E; Boon AP; Whelan P
Br J Radiol; 1998 Nov; 71(851):1130-5. PubMed ID: 10434906
[TBL] [Abstract][Full Text] [Related]
20. [Value of PSA and (pre- postoperative) Gleason in predicting the potential lymphatic involvement in patients with prostatic cancer].
Gómez Veiga F; Díaz Bermúdez J; Alvarez Castelo L; Lorenzo Patiño MJ; Rodríguez Rivera J; Chantada Abal V; Vázquez Martul E; González Martín M
Arch Esp Urol; 1997; 50(1):33-9. PubMed ID: 9182486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
